RxDoctor Payments Data

Justin Weigel, OD

Optometrist · Olathe, KSNPI 1225220346

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $136,963 of the $220,142 with a category attached, or 62.2%. Bausch & Lomb Americas Inc. accounts for 66.8% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $75,433 and has fallen 78.1% since, to $16,517 in 2025. Among optometrist clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$220,142in general payments, 2019–2025

Across 512 payments — averaging $429.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$147K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$71K
  • Biotissue Holdings Inc.$351
  • Aerie Pharmaceuticals, Inc.$232
  • Coopervision Inc.$211
  • Alcon$205
  • plus $955 from 10 others

What the payments were for

  • Consulting fees$19,7009%
  • Speaking & faculty fees$136,96362%
  • Travel & lodging$50,17123%
  • Food & beverage$13,3086%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$220,142 in reported general payments places this provider in the 95th percentile of 567 optometrist providers in Kansas.

See all optometrist providers in Kansas

Medicare billing

Part B allowed, 2024
$17,550
Medicare patients
86
Services billed
193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost29$498

Paid to pharmacies, not to this prescriber.

Other optometrist in Olathe

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →